Geovax Labs
$1.23
126
-$0.02-1.6% Today
Statistics
Day High
1.29
Day Low
1.23
52W High
34.75
52W Low
1.23
Volume
21,251
Avg. Volume
135,721
Mkt Cap
36.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
-3.63625
Actual EPS
N/A
Financials
-631.91%Profit Margin
Unprofitable7.91MRevenue
-49.98MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GOVX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.25B
Moderna
MRNA
Mkt Cap19.51B
BioNTech
BNTX
Mkt Cap22.92B
Johnson & Johnson
JNJ
Mkt Cap585.7B
Pfizer
PFE
Mkt Cap161.09B
Inovio Pharmaceuticals
INO
Mkt Cap78.07M
GSK
GSK
Mkt Cap113.29B
Sanofi
SNY
Mkt Cap116.63B
Arbutus Biopharma
ABUS
Mkt Cap875.74M
About
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Show more...
CEO
Mr. David Alan Dodd
Employees
17
Country
US
ISIN
US3736787058
Listings
0 Comments
Share your thoughts
FAQ
What is Geovax Labs stock price today?▼
The current price of GOVX is $1.23 USD — it has decreased by -1.6% in the past 24 hours. Watch Geovax Labs stock price performance more closely on the chart.
What is Geovax Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Geovax Labs stocks are traded under the ticker GOVX.
Is Geovax Labs stock price growing?▼
GOVX stock has fallen by -10.87% compared to the previous week, the month change is a -31.28% fall, over the last year Geovax Labs has showed a -94.83% decrease.
What is Geovax Labs market cap?▼
Today Geovax Labs has the market capitalization of 36.54M
When is the next Geovax Labs earnings date?▼
Geovax Labs is going to release the next earnings report on April 30, 2026.
What were Geovax Labs earnings last quarter?▼
GOVX earnings for the last quarter are -7.75 USD per share, whereas the estimation was -5.85 USD resulting in a -32.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Geovax Labs revenue for the last year?▼
Geovax Labs revenue for the last year amounts to 7.91M USD.
What is Geovax Labs net income for the last year?▼
GOVX net income for the last year is -49.98M USD.
How many employees does Geovax Labs have?▼
As of April 07, 2026, the company has 17 employees.
In which sector is Geovax Labs located?▼
Geovax Labs operates in the Health Care sector.
When did Geovax Labs complete a stock split?▼
The last stock split for Geovax Labs was on January 12, 2026 with a ratio of 1:25.
Where is Geovax Labs headquartered?▼
Geovax Labs is headquartered in Smyrna, US.